Gilead Sciences to Present at Upcoming Investor Conferences
Gilead Sciences (GILD) has announced its executive participation in two upcoming investor conferences in March. The company will present at the TD Cowen Annual Health Care Conference on March 4 at 11:10 AM ET and the Leerink Partners Global Healthcare Conference on March 11 at 10:40 AM ET.
Live webcasts will be available on Gilead's investor page (investors.gilead.com), with replays accessible for at least 30 days post-presentation. Gilead Sciences is a biopharmaceutical company with over three decades of breakthrough medical achievements, focusing on innovative medicines for HIV, viral hepatitis, COVID-19, and cancer treatments. The company maintains operations in more than 35 countries, with its headquarters in Foster City, California.
Gilead Sciences (GILD) ha annunciato la sua partecipazione esecutiva a due conferenze per investitori in programma a marzo. L'azienda presenterà alla TD Cowen Annual Health Care Conference il 4 marzo alle 11:10 AM ET e alla Leerink Partners Global Healthcare Conference l'11 marzo alle 10:40 AM ET.
Le dirette streaming saranno disponibili sulla pagina per investitori di Gilead (investors.gilead.com), con le registrazioni accessibili per almeno 30 giorni dopo la presentazione. Gilead Sciences è un'azienda biofarmaceutica con oltre tre decenni di successi medici innovativi, concentrandosi su farmaci innovativi per HIV, epatite virale, COVID-19 e trattamenti per il cancro. L'azienda opera in oltre 35 paesi, con sede a Foster City, California.
Gilead Sciences (GILD) ha anunciado su participación ejecutiva en dos próximas conferencias para inversores en marzo. La compañía presentará en la TD Cowen Annual Health Care Conference el 4 de marzo a las 11:10 AM ET y en la Leerink Partners Global Healthcare Conference el 11 de marzo a las 10:40 AM ET.
Las transmisiones en vivo estarán disponibles en la página de inversores de Gilead (investors.gilead.com), con repeticiones accesibles durante al menos 30 días después de la presentación. Gilead Sciences es una empresa biofarmacéutica con más de tres décadas de logros médicos innovadores, centrándose en medicamentos innovadores para el VIH, hepatitis viral, COVID-19 y tratamientos contra el cáncer. La empresa mantiene operaciones en más de 35 países, con sede en Foster City, California.
길리어드 사이언스(GILD)는 3월에 예정된 두 개의 투자자 회의에 대한 경영진 참여를 발표했습니다. 이 회사는 3월 4일 오전 11시 10분 ET에 TD Cowen 연례 건강 관리 회의에 참석하고, 3월 11일 오전 10시 40분 ET에 리링크 파트너스 글로벌 헬스케어 회의에 참석할 예정입니다.
실시간 웹캐스트는 길리어드의 투자자 페이지(investors.gilead.com)에서 제공되며, 발표 후 최소 30일 동안 다시 볼 수 있습니다. 길리어드 사이언스는 HIV, 바이러스성 간염, COVID-19 및 암 치료를 위한 혁신적인 의약품에 중점을 두고 30년 이상의 혁신적인 의료 성과를 가진 생명공학 회사입니다. 이 회사는 35개 이상의 국가에서 운영되며, 본사는 캘리포니아주 포스터 시티에 있습니다.
Gilead Sciences (GILD) a annoncé sa participation exécutive à deux conférences pour investisseurs à venir en mars. L'entreprise présentera à la TD Cowen Annual Health Care Conference le 4 mars à 11h10 ET et à la Leerink Partners Global Healthcare Conference le 11 mars à 10h40 ET.
Des webinaires en direct seront disponibles sur la page des investisseurs de Gilead (investors.gilead.com), avec des rediffusions accessibles pendant au moins 30 jours après la présentation. Gilead Sciences est une entreprise biopharmaceutique avec plus de trois décennies de réalisations médicales révolutionnaires, axée sur des médicaments innovants pour le VIH, l'hépatite virale, le COVID-19 et les traitements du cancer. L'entreprise opère dans plus de 35 pays, avec son siège à Foster City, Californie.
Gilead Sciences (GILD) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im März angekündigt. Das Unternehmen wird am 4. März um 11:10 Uhr ET auf der TD Cowen Annual Health Care Conference und am 11. März um 10:40 Uhr ET auf der Leerink Partners Global Healthcare Conference präsentieren.
Live-Übertragungen werden auf der Investorenseite von Gilead (investors.gilead.com) verfügbar sein, mit Wiederholungen, die mindestens 30 Tage nach der Präsentation zugänglich sind. Gilead Sciences ist ein biopharmazeutisches Unternehmen mit über drei Jahrzehnten bahnbrechender medizinischer Errungenschaften und konzentriert sich auf innovative Medikamente zur Behandlung von HIV, Virushepatitis, COVID-19 und Krebs. Das Unternehmen ist in mehr als 35 Ländern tätig und hat seinen Hauptsitz in Foster City, Kalifornien.
- None.
- None.
- TD Cowen Annual Health Care Conference on Tuesday, March 4 at 11:10 AM Eastern Time
- Leerink Partners Global Healthcare Conference on Tuesday, March 11 at 10:40 AM Eastern Time
The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250219400385/en/
Jacquie Ross, CFA – Investors
investor_relations@gilead.com
Source: Gilead Sciences, Inc.
FAQ
When is Gilead Sciences (GILD) presenting at the TD Cowen Healthcare Conference in 2024?
How can investors access GILD's March 2024 conference presentations?
What therapeutic areas does Gilead Sciences (GILD) focus on?
How many countries does Gilead Sciences (GILD) operate in?
When is GILD presenting at the Leerink Partners Conference in 2024?
